INSULIN DEGLUDEC

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 20:36:01 GMT 2025` Edited by `admin` on `Mon Mar 31 20:36:01 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	54Q18076QB
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

RYZODEG 70/30 COMPONENT INSULIN DEGLUDEC

Preferred Name

English

INSULIN DEGLUDEC

Official Name

English

TRESIBA

Brand Name

English

Insulin degludec [WHO-DD]

Common Name

English

NN-1250

Code

English

INSULIN DEGLUDEC [JAN]

Common Name

English

INSULIN DEGLUDEC [EMA EPAR]

Common Name

English

insulin degludec [INN]

Common Name

English

INSULIN DEGLUDEC [USAN]

Common Name

English

XULTOPHY 100/3.6 COMPONENT INSULIN DEGLUDEC

Brand Name

English

(1A-21A),(1B-29B)-INSULIN (HUMAN), 29B-(N6-(N-(15-CARBOXY-1-OXOPENTADECYL)-L-.GAMMA.-GLUTAMYL)-L-LYSINE)-

Common Name

English

NN1250

Code

English

INSULIN DEGLUDEC [ORANGE BOOK]

Common Name

English

Classification Tree Code System Code

WHO-ATC

A10AE06

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

WHO-ATC

A10AD06

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

NDF-RT

N0000175453

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

WHO-VATC

QA10AE06

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

WHO-ATC

A10AE56

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

WHO-VATC

QA10AD06

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

NCI_THESAURUS

C581

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

Code System Code Type Description

RXCUI

1670007

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

RxNorm

MESH

C571886

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

DAILYMED

54Q18076QB

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

USAN

YY-04

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

CAS

844439-96-9

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

ChEMBL

CHEMBL2107869

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

NCI_THESAURUS

C142979

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

FDA UNII

54Q18076QB

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

EVMPD

SUB96394

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

DRUG CENTRAL

4960

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

DRUG BANK

DB09564

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

INN

9170

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

SMS_ID

100000141767

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

WIKIPEDIA

INSULIN DEGLUDEC

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

PUBCHEM

118984462

Created by admin on Mon Mar 31 20:36:01 GMT 2025 , Edited by admin on Mon Mar 31 20:36:01 GMT 2025

PRIMARY

From	To
1_7	2_7
1_19	2_20
2_6	2_11

Related Record Type Details


					54Q18076QB

INSULIN DEGLUDEC

ACTIVE MOIETY

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_29]		K		N6-(N-(15-CARBOXY-1-OXOPENTADECYL)-L-.GAMMA.-GLUTAMYL)-L-LYSINE	3A95UEM7F7

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC

MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL